AMZN has quietly clawed back to $261 — up 0.6% on the week and 12.5% over the past month — yet the gap between where the stock trades and where analysts think it should be remains stubbornly wide.
The Street's positioning is the clearest story this week. The consensus price target clusters around $327, roughly 25% above the current price, and the direction of recent analyst revisions has been uniformly upward. Following the last earnings print, UBS raised its target to $318 from $305, Citigroup moved to $350 from $325, TD Cowen to $350 from $340, and RBC Capital to $330 from $320 — all maintaining positive ratings. Rosenblatt assumed coverage on August 20 with a Buy and a $335 target, the most recent action in the data. The lone exception is DA Davidson, sitting at Neutral with a $250 target — essentially flat to the current price. EPS momentum is exceptional, ranking in the 96th percentile on a 30-day basis and the 91st on a 90-day basis, with an EPS surprise rank of 94. The bull case rests on AWS demand, the OpenAI partnership, and Trainium-driven AI infrastructure expansion. The bear case centres on eCommerce competition and margin risk from the aggressive capex cycle — Amazon raised its 2026 AI infrastructure spending target to $220 billion, a number that continues to provoke debate about returns.
Positioning from the lending market is entirely uneventful, and that itself is worth stating plainly. Short interest is running just under 1% of the free float — among the lowest readings for any large-cap in the universe. It has drifted lower on the week, off about 1.5%, and is down more than 5% from a month ago. The big move already happened: the August 11 cover event that cut short positions from roughly 107 million shares to around 97 million remains the dominant positioning shift of the past month. Borrow availability is effectively unlimited, and cost to borrow at 0.25% is negligible. There is no short-side tension here at all.
Options tell a similarly relaxed story. The put/call ratio has normalised back toward its 20-day average after last week's notably call-heavy reading of 0.66. The current PCR is 0.71, just 0.4 standard deviations above the 20-day mean of 0.70 — firmly in the middle of the past year's range, with the 52-week high at 0.91 and the low at 0.60. The spike toward 0.81 seen on Monday has already faded. Neither bulls nor bears are making aggressive directional bets through the options market right now.
Institutional flow is broadly constructive. BlackRock added 12.8 million shares in its most recent filing. Capital Research added 12.3 million. FMR added 6.9 million. These are steady accumulations from index and active managers, not repositioning. Insider activity is routine: CFO Brian Olsavsky sold 6,172 shares on August 21 following an award grant, and CLO David Zapolsky sold 9,258 shares on August 24 — both well within normal compensation-plan mechanics. Net insider activity over 90 days is a modest positive 44,848 shares, with no signal of meaningful directional intent.
The next earnings event is October 30. The two most recent prints each produced next-day moves above 19% — the kind of reaction that makes the period into that release the obvious thing to track, as the market will be weighing whether AI capex commitments are translating into accelerating AWS margin expansion.
See the live data behind this article on ORTEX.
Open AMZN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
